CXCR4 and glioblastoma: These encouraging results suggest that [68Ga]Ga-TD-01 could be effectively translated into clinical practice for in vivo characterization of CXCR4 expression in GBM and other CXCR4-implicated cancers, with significant potential for improving cancer diagnosis.